Temporal code and speech recognition.

A Kral

doi:10.1080/000164800750046045

Home/Archive/PubMed

PubMed · 10958406

Temporal code and speech recognition.

A Kral

View original source ↗Export metadata ↓

Abstract

The hypothesis that temporal code is mainly responsible for speech recognition is discussed. Data from cochlear implant research demonstrate that single-channel speech processors, supplying only temporal code, enable understanding of spoken language. Physiological findings supporting the observation are presented. A temporal theory of tone pitch perception is discussed.

Explore related subjects

Cochlea Cochlear Implantation Cochlear Nerve Humans Pitch Perception Speech Perception Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

A Kral. 2000. Temporal code and speech recognition.. https://doi.org/10.1080/000164800750046045

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

Effect of MRI noise on cochlear function.

A disadvantage of magnetic resonance imaging (MRI) is the high level of noise produced (peaking between 122 dB and 131 dB). We used otoacoustic emissions (OAEs) as a method to quantify the effect of MRI-generated noise on the cochlea. OAEs were measured in 16 patients before and after MRI and in 16 controls. OAEs decreased in patients after MRI, but the controls, who were not exposed to MRI noise, showed no decrease over the same period. The change in OAEs shows a clear effect of MRI noise on cochlear function, despite use of earplugs. The importance of correctly fitted earplugs cannot be underestimated.

Cochlea↗

PubMed2002

Surgery and functional outcomes in deaf children receiving cochlear implants before age 2 years.

OBJECTIVE: To examine the feasibility of cochlear implantation in children younger than 2 years regarding surgery and functional outcomes. DESIGN: Prospective study. SETTING: Tertiary pediatric cochlear implant center. PATIENTS: A consecutive sample of 12 children younger than 2 years at the time of cochlear implantation (8 boys and 4 girls). The cause of hearing loss was meningitis in 6 children and congenital in 6. INTERVENTIONS: Multichannel cochlear implantation using the Nucleus C124M (Cochlear Co, Sydney, Australia) device. Functional outcome was assessed using the Listening Progress Profile and the Categories of Auditory Performance. MAIN OUTCOME MEASURES: Perioperative and postoperative surgical complications and functional outcome. RESULTS: Eight children had a completely patent cochlea. Four children required a 3- to 5-mm drilling to reach the scala tympani because of ossification after meningitis. Full insertion was achieved in 11 patients; the other child received 18 electrodes. One patient had temporary facial nerve weakness; 2 others had wound edema and serous discharge that resolved with conservative management. In the longer term, 1 child experienced a single episode of acute otitis media; another had recurrent episodes of otitis media. Mean Listening Progress Profile scores increased from 1 to 42 and median Categories of Auditory Performance scores increased from 0 to 5 at 2 years postsurgery. Comparison with the scores in the 2- to 5-year group showed no significant differences. No significant tuning difficulties were experienced with all children. CONCLUSIONS: Cochlear implantation is feasible in children younger than 2 years without significant surgical complications or particular tuning difficulties. Functional results 2 years after implantation were as good as or better than those of children who underwent implantation between ages 2 and 5 years.

Cochlea↗

PubMed2002

Clinical experience with caroverine in inner ear diseases.

The glutamatergic synapses between the cochlear inner hair cells and their afferent neurons seem to be mostly involved in the pathophysiology of the cochlea. Glutamatergic neurotoxicity is characterized by a mitochondrial overproduction of free oxygen radicals damaging lipid membranes and DNA structures of the postsynaptic neuron followed by the clinical symptoms of hearing loss and tinnitus. In preclinical tests, quinoxaline derivatives antagonized these deleterious consequences of too high an amount of free radicals. Therefore the clinically available quinoxaline dione caroverine provides a new approach to a successful treatment of tinnitus, sudden hearing loss and speech discrimination disorders in presbyacusis. The results of corresponding clinical trials are presented.

Cochlea↗